Skip to main content

Table 4 ORs and 95% CIs for FOS member mRNA expression in tumors with clinicopathological parameters

From: Expression of activator protein-1 (AP-1) family members in breast cancer

Parameter

OR (95% CI)

c-Fos

Fra-1

Fra-2

Fos-B

Menopausal status

Pre-menopause

1

1

1

1

Post-menopause

0.95 (0.71-1.26)

1.24 (0.72-2.14)

0.78 (0.48-1.26)

0.84 (0.60-1.19)

P value

0.71

0.43

0.32

0.33

Lymph node status

Negative

1

1

1

1

Positive

0.72 (0.50-1.06)

0.43 (0.22-0.83)

0.83 (0.49-1.41)

1.00 (0.70-1.46)

P value

0.09

0.01*

0.49

0.98

Stage

I

1

1

1

1

II

1.18 (0.70-2.01)

0.71 (0.29-1.75)

0.83 (0.38-1.82)

1.02 (0.58-1.78)

III and IV

0.75 (0.44-1.26)

0.37 (0.14-0.99)

0.78 (0.35-1.76)

0.86 (0.48-1.53)

P value

0.02*

0.05*

0.84

0.64

Grade

1

1

1

1

1

2

0.62 (0.42-0.94)

0.99 (0.56-1.76)

1.14 (0.62-1.90)

0.62 (0.41-0.93)

3

0.70 (0.37-1.29)

1.15 (0.42-3.17)

1.23 (0.50-3.04)

0.73 (0.37-1.44)

P value

0.04*

0.95

0.83

0.05*

  1. ORs and CIs from logistic regression model, stratified on some parameters including menopausal and lymph node statuses, grade and stage.
  2. Abbreviations: OR, Odds ratio; CI, Confidence interval.
  3. *Statistically significant (p < 0.05 in two-tailed test).